COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Countries in sub-Saharan Africa could see thousands of deaths from HIV due to cuts to the US President’s Emergency Plan for AIDS Relief (PEPFAR), underscoring the necessity of reinstating the program.

Major setbacks in the global fight against HIV may be imminent due to recent funding cuts, public health experts have warned ...

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...

The sudden and notorious closure of USAID by Elon Musk last January — “I fed it into the wood-chipper,” the world’s richest ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

The Gates Foundation’s global AIDS work is admirable, but it relies on large U.S. government co-financing. Aid advocate ONE ...

The Infected Blood inquiry will publish a report on Wednesday about the way the government is managing compensation for ...

Gilead and its partners' efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets ...

GOP eyes limits on legal immigration In the wake of Zohran Mamdani’s stunning win in the New York City Democratic mayoral primary, Republicans on Capitol Hill are pondering a new issue — restricting ...